BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NIA IMPACT Collaboratory - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://impactcollaboratory.org
X-WR-CALDESC:Events for NIA IMPACT Collaboratory
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230921T120000
DTEND;TZID=America/New_York:20230921T130000
DTSTAMP:20260424T231057
CREATED:20230825T174431Z
LAST-MODIFIED:20230825T174957Z
UID:13049-1695297600-1695301200@impactcollaboratory.org
SUMMARY:Grand Rounds: James Flory\, MD\, MSCE | Decision Architecture Randomization Trials: Extremely Low-Cost Trials with Preservation of Clinician and Patient Choice
DESCRIPTION:Join us for IMPACT Grand Rounds on Thursday\, September 21 at 12pm ET with Dr. James Flory who will be presenting on the “Decision Architecture Randomization Trials: Extremely Low-Cost Trials with Preservation of Clinician and Patient Choice.” \nDr. James Flory is an endocrinologist and clinical epidemiologist at Memorial Sloan Kettering Cancer Center\, specializing in the management of hyperglycemia and diabetes in cancer patients. Dr. Flory’s research career began with a pre-doctoral fellowship in bioethics at the NIH\, where his work on ethical and logistical challenges to traditional randomized controlled trials led him to become very interested in alternative clinical research approaches\, especially observational studies. Much of his subsequent career has focused on the application of observational study methodologies to answer comparative effectiveness questions\, supported by funding from AHRQ\, NIH\, and PCORI. His research has largely focused on diabetes care\, particularly around metformin use\, and he was part of a successful effort to revise the Food and Drug Administration (FDA) label for metformin to make it accessible to hundreds of thousands of patients for whom it had been inappropriately contraindicated. In recent years\, Dr. Flory’s research has increasingly focused on the intersection of diabetes and cancer treatment\, with a particular focus on supportive care in patients with hyperglycemia in the setting of breast and pancreatic cancer. His major research focus now is a PCORI-funded methods development project to work on a novel pragmatic trial design called a Decision Architecture Randomization Trial (DART). DART is intended to permit extremely efficient\, low-cost\, and safe studies of clinical comparative effectiveness questions that would not be likely to attract the resources needed for a traditional clinical trial. \n  \nZoom Conferencing\nJoin from PC\, Mac\, iOS or Android: https://hebrewseniorlife.zoom.us/j/97344810673\nDial-In:  +1 312 626 6799 (US Toll) or  +1 470 250 9358 (US Toll)\nMeeting ID:  973 4481 0673 \nPDF Flyer: IMPACT GR | J. Flory – 9.21.23
URL:https://impactcollaboratory.org/event/grand-rounds-james-flory-md-msce-decision-architecture-randomization-trials-extremely-low-cost-trials-with-preservation-of-clinician-and-patient-choice/
LOCATION:https://hebrewseniorlife.zoom.us/j/86937720056 
CATEGORIES:Grand Rounds,upcoming
END:VEVENT
END:VCALENDAR